Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers (Nature Metabolism, (2020), 2, 12, (1413-1426), 10.1038/s42255-020-00313-3)

Yu Hsi Lin; Nikunj Satani; Naima Hammoudi; Victoria C. Yan; Yasaman Barekatain; Sunada Khadka; Jeffrey J. Ackroyd; Dimitra K. Georgiou; Cong Dat Pham; Kenisha Arthur; David Maxwell; Zhenghong Peng; Paul G. Leonard; Barbara Czako; Federica Pisaneschi; Pijus Mandal; Yuting Sun; Rafal Zielinski; Susana Castro Pando; Xiaobo Wang; Theresa Tran; Quanyu Xu; Qi Wu; Yongying Jiang; Zhijun Kang; John M. Asara; Waldemar Priebe; William Bornmann; Joseph R. Marszalek; Ronald A. DePinho; Florian L. Muller

doi:10.1038/s42255-020-00335-x

Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers (Nature Metabolism, (2020), 2, 12, (1413-1426), 10.1038/s42255-020-00313-3)

Yu Hsi Lin, Nikunj Satani, Naima Hammoudi, Victoria C. Yan, Yasaman Barekatain, Sunada Khadka, Jeffrey J. Ackroyd, Dimitra K. Georgiou, Cong Dat Pham, Kenisha Arthur, David Maxwell, Zhenghong Peng, Paul G. Leonard, Barbara Czako, Federica Pisaneschi, Pijus Mandal, Yuting Sun, Rafal Zielinski, Susana Castro Pando, Xiaobo WangTheresa Tran, Quanyu Xu, Qi Wu, Yongying Jiang, Zhijun Kang, John M. Asara, Waldemar Priebe, William Bornmann, Joseph R. Marszalek, Ronald A. DePinho, Florian L. Muller

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the version of this article initially published, support of S.K. by MD Anderson Cancer Center CPRIT Research Training Program Grant RP170067 was not included in the Acknowledgements.

Original language	English (US)
Pages (from-to)	122
Number of pages	1
Journal	Nature Metabolism
Volume	3
Issue number	1
DOIs	https://doi.org/10.1038/s42255-020-00335-x
State	Published - Jan 2021

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Cell Biology
Physiology (medical)

Access to Document

10.1038/s42255-020-00335-x

Cite this

Lin, Y. H., Satani, N., Hammoudi, N., Yan, V. C., Barekatain, Y., Khadka, S., Ackroyd, J. J., Georgiou, D. K., Pham, C. D., Arthur, K., Maxwell, D., Peng, Z., Leonard, P. G., Czako, B., Pisaneschi, F., Mandal, P., Sun, Y., Zielinski, R., Pando, S. C., ... Muller, F. L. (2021). Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers (Nature Metabolism, (2020), 2, 12, (1413-1426), 10.1038/s42255-020-00313-3). Nature Metabolism, 3(1), 122. https://doi.org/10.1038/s42255-020-00335-x

Lin, YH, Satani, N, Hammoudi, N, Yan, VC, Barekatain, Y, Khadka, S, Ackroyd, JJ, Georgiou, DK, Pham, CD, Arthur, K, Maxwell, D, Peng, Z, Leonard, PG, Czako, B, Pisaneschi, F, Mandal, P, Sun, Y, Zielinski, R, Pando, SC, Wang, X, Tran, T, Xu, Q, Wu, Q, Jiang, Y, Kang, Z, Asara, JM, Priebe, W, Bornmann, W, Marszalek, JR, DePinho, RA & Muller, FL 2021, 'Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers (Nature Metabolism, (2020), 2, 12, (1413-1426), 10.1038/s42255-020-00313-3)', Nature Metabolism, vol. 3, no. 1, pp. 122. https://doi.org/10.1038/s42255-020-00335-x

@article{29ef7699903848858306448b2e96b12e,

title = "Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers (Nature Metabolism, (2020), 2, 12, (1413-1426), 10.1038/s42255-020-00313-3)",

abstract = "In the version of this article initially published, support of S.K. by MD Anderson Cancer Center CPRIT Research Training Program Grant RP170067 was not included in the Acknowledgements.",

author = "Lin, {Yu Hsi} and Nikunj Satani and Naima Hammoudi and Yan, {Victoria C.} and Yasaman Barekatain and Sunada Khadka and Ackroyd, {Jeffrey J.} and Georgiou, {Dimitra K.} and Pham, {Cong Dat} and Kenisha Arthur and David Maxwell and Zhenghong Peng and Leonard, {Paul G.} and Barbara Czako and Federica Pisaneschi and Pijus Mandal and Yuting Sun and Rafal Zielinski and Pando, {Susana Castro} and Xiaobo Wang and Theresa Tran and Quanyu Xu and Qi Wu and Yongying Jiang and Zhijun Kang and Asara, {John M.} and Waldemar Priebe and William Bornmann and Marszalek, {Joseph R.} and DePinho, {Ronald A.} and Muller, {Florian L.}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2021",

month = jan,

doi = "10.1038/s42255-020-00335-x",

language = "English (US)",

volume = "3",

pages = "122",

journal = "Nature Metabolism",

issn = "2522-5812",

publisher = "Springer Berlin",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - An enolase inhibitor for the targeted treatment of ENO1-deleted cancers (Nature Metabolism, (2020), 2, 12, (1413-1426), 10.1038/s42255-020-00313-3)

AU - Lin, Yu Hsi

AU - Satani, Nikunj

AU - Hammoudi, Naima

AU - Yan, Victoria C.

AU - Barekatain, Yasaman

AU - Khadka, Sunada

AU - Ackroyd, Jeffrey J.

AU - Georgiou, Dimitra K.

AU - Pham, Cong Dat

AU - Arthur, Kenisha

AU - Maxwell, David

AU - Peng, Zhenghong

AU - Leonard, Paul G.

AU - Czako, Barbara

AU - Pisaneschi, Federica

AU - Mandal, Pijus

AU - Sun, Yuting

AU - Zielinski, Rafal

AU - Pando, Susana Castro

AU - Wang, Xiaobo

AU - Tran, Theresa

AU - Xu, Quanyu

AU - Wu, Qi

AU - Jiang, Yongying

AU - Kang, Zhijun

AU - Asara, John M.

AU - Priebe, Waldemar

AU - Bornmann, William

AU - Marszalek, Joseph R.

AU - DePinho, Ronald A.

AU - Muller, Florian L.

PY - 2021/1

Y1 - 2021/1

N2 - In the version of this article initially published, support of S.K. by MD Anderson Cancer Center CPRIT Research Training Program Grant RP170067 was not included in the Acknowledgements.

AB - In the version of this article initially published, support of S.K. by MD Anderson Cancer Center CPRIT Research Training Program Grant RP170067 was not included in the Acknowledgements.

UR - http://www.scopus.com/inward/record.url?scp=85097780412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097780412&partnerID=8YFLogxK

U2 - 10.1038/s42255-020-00335-x

DO - 10.1038/s42255-020-00335-x

M3 - Comment/debate

C2 - 33340032

AN - SCOPUS:85097780412

SN - 2522-5812

VL - 3

SP - 122

JO - Nature Metabolism

JF - Nature Metabolism

IS - 1

ER -

Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers (Nature Metabolism, (2020), 2, 12, (1413-1426), 10.1038/s42255-020-00313-3)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this